Latest news

Insights

Top 10 AI Risks Every Pharmaceutical Executive Should Understand

Executive Summary Artificial intelligence (AI) is becoming embedded across pharmaceutical research, clinical development, manufacturing, medical affairs, pharmacovigilance, and commercial operations....
Insights

The Rise of Autonomous Laboratories

Executive Summary Pharmaceutical research is entering a new phase of automation. For decades, laboratories have adopted individual technologies to automate repetitive...
Clinical

Phase 3 of Ultragenyx fails to plot “significant expense reductions” using the Angelman test

Ultragenyx had been on a roll with its recent FDA approval of Genglycos, but the company has finally been...
Clinical

Following the cancelation of more phase 3 trials, Novo’s blockbuster aspirations for the CKD program decline

Novo's:The prospects for ziltivekimab, a drug that analysts had previously predicted would be a blockbuster, have been further damaged...
Clinical

Ziihera Delivers Second Survival Win in Advanced HER2-Positive Stomach Cancer Trial

Jazz Pharmaceuticals has reported a second positive overall survival...
Insights

How Synthetic Data Is Changing Clinical Research

Executive Summary Clinical research depends on data, but access to...
Regulatory

FDA Approves Eli Lilly’s Mounjaro to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s Mounjaro (tirzepatide) to reduce the risk of major...
Commercial

Roche’s Genentech Partners With DualityBio on ADCs Designed to Address Cancer Drug Resistance

Roche’s Genentech has entered into a collaboration and licensing agreement with Shanghai-based DualityBio to develop antibody-drug conjugates (ADCs) intended...
Insights

Top 10 Technologies Improving Market Access in Pharma

Executive Summary Market access has become increasingly complex as pharmaceutical companies navigate evolving reimbursement models, rising evidence requirements, pricing pressure,...
Insights

Top 10 Innovations in Target Identification in Drug Development

Executive Summary Target identification is one of the most consequential...
Commercial

Cureety Buys Out AI-Focused Oncology Firm Reimagine Care

Precision oncology care firm Cureety has acquired artificial intelligence-powered...
Commercial

Novartis and Alteogen sign a $3.2 billion subcutaneous medication delivery agreement

With South Korea's Alteogen, Novartis has secured access to the biotech's exclusive subcutaneous drug delivery platform, ALT-B4, through an...
Insights

Top 10 Data Governance Priorities for Life Sciences Leaders

Executive Summary Data has become one of the most important strategic assets across the life sciences industry. Pharmaceutical and biotechnology...
Insights

Agentic AI in Life Sciences

Executive Summary Artificial intelligence in life sciences is moving beyond systems that simply generate answers or analyze information. The next stage...
Commercial

Pfizer and Flynn Pharma face charges in UK for unfair price hike of epilepsy drug

The U.K.’s competition watchdog claimed that Pfizer and Flynn...
Commercial

Roche’s Genentech Partners With DualityBio on ADCs Designed to Address Cancer Drug Resistance

Roche’s Genentech has entered into a collaboration and licensing...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Regulatory

Insights

The Rise of Autonomous Laboratories

Executive Summary Pharmaceutical research is entering a new phase of...
Clinical

Phase 3 of Ultragenyx fails to plot “significant expense reductions” using the Angelman test

Ultragenyx had been on a roll with its recent...
Clinical

Following the cancelation of more phase 3 trials, Novo’s blockbuster aspirations for the CKD program decline

Novo's:The prospects for ziltivekimab, a drug that analysts had...
Commercial

GSK Signs Deal With Hutchmed to Get Early-Stage KRAS-EGFR Cancer Asset

GSK is paying big bucks to Hutchmed to obtain...

Research & Development

Market Access

Manufacturing

Daiichi Revises ADC Supply Plans After Changes in Cancer Drug Demand Forecasts

Daiichi Sankyo said changes in projected demand for several...
Manufacturing

Lilly Adds $4.5 Billion to Indiana Manufacturing Expansion, Total U.S. Commitments Exceed $50 Billion

Eli Lilly has announced an additional $4.5 billion investment...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 AI Risks Every Pharmaceutical Executive Should Understand

Executive Summary Artificial intelligence (AI) is becoming embedded across pharmaceutical...
Editorial Team -
Manufacturing

Aura Biosciences Refocuses on Ocular Oncology Programs and Cuts Workforce by 20%

Aura Biosciences is restructuring its operations under recently appointed...
Editorial Team -